期刊文献+

对应用糖皮质激素治疗结核性胸膜炎合并2型糖尿病患者32例护理的体会 被引量:3

Nursing experience of using glucocorticoid treating type 2 diabetic patients with tuberculous pleurisy in 32 cases
下载PDF
导出
摘要 目的:探讨对应用糖皮质激素治疗结核性胸膜炎合并2型糖尿病患者护理的体会。方法:收治结核性胸膜炎合并2型糖尿病患者32例,在强化抗痨药物的基础上,给予糖皮质激素治疗,观察临床疗效。结果:28例患者在1周左右控制症状,胸水10d左右吸收。4例患者胸水4~5周吸收,2例发生轻度低血糖,经调整胰岛素剂量后好转。结论:糖皮质激素治疗结核性胸膜炎合并2型糖尿病患者具有满意的临床疗效。 Objective:To explore the nursing experience of glucocorticoid in the treatment of type 2 diabetic patients withtuberculous pleurisy.Methods:32 cases of type 2 diabetic patients with tuberculous pleurisy were selected.On the basis ofstrengthening antituberculosis drug,they were given glucocorticoid treatment.The clinical curative effect was observed.Results:The symptoms of 28 patients were controlled at about 1 week,and the pleural effusion was absorbed about 10 days.The pleuraleffusions of 4 patients were absorbed for 4 to 5 weeks.2 cases had mild hypoglycemia,they were improved after adjustment ofinsulin dose.Conclusion:Glucocorticoid in the treatment of type 2 diabetic patients with tuberculous pleurisy has a satisfactoryclinical curative effect.
作者 龚诚成 倪小英 房爱杰 范桂秋 傅聿明 Gong Chengcheng;Ni Xiaoying;Fang Aijie;Fan Guiqiu;Yuming(Xinghua City People's Hospital of Jiangsu Province 225700)
出处 《中国社区医师》 2015年第34期121-122,共2页 Chinese Community Doctors
关键词 结核性胸膜炎 2 型糖尿病 糖皮质激素 护理体会 Tuberculous pleurisy Type 2 diabetic Glucocorticoid Nursing experience
  • 相关文献

参考文献6

二级参考文献34

  • 1谢虹,刘纯艳.糖尿病健康教育实施要素[J].护理学杂志,2005,20(7):71-74. 被引量:81
  • 2范丽凤,陆菊明,田慧,潘长玉.全程糖尿病教育模式的构建、组织与管理[J].现代护理,2005,11(8):575-579. 被引量:88
  • 3Jamieson PM, Nyirenda M_J, Walker BR, et al. Interactions between oestradiol and glucocorticoid regulatory effects on liver- specific glucocortieoid- inducible genes; possible evidence for a role of hepatic llbeta- hydroxysteroid dehydrogenase type 1. J Endocrinol 1999;160(1) :103- 109.
  • 4Lundgren M, Buren J, Ruge T, et al. Glucocorticoids down -regulate glucose uptake capacity and insulin - signaling proteins in omental but not subcutaneous human adipocytes. J Clin Endocrinol Metab 2004 ;89(6) .-2989- 2997.
  • 5Delaunay F, Khan A, Cintra A, et al. Pancreatic beta ceils are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 1997;100(8) :2094- 2098.
  • 6Pauthakalam S, Bhatnagar D, Klimiuk P. The prevalence and management of hyperglycemia in patients with rheumatoid arthritis on corticosteroid therapy. Scott Med J 2004 ;49(4) : 139 - 141.
  • 7Hoogwerf B, Danese RD. Drug selection and the management of corticosteroid - related diabetes mellitas. Rheum Dis Clin North Am 1999 ;25 (3) : 489 - 505.
  • 8Gurwitz J, Bohn R, Glynn R, et al. Glucocorticoids and the risk for initiation of hypoglycemia therapy. Arch Intern Med 1994; 154(1):97- 101.
  • 9Midtvedt K, Hjelmesaeth J, Hartmann A, et al. Insulin resistance after renal transplantation: the effect of steroid dose reductionand with drawal. J Am Soe Nephrol 2004 ; 15 (12) : 3233 - 3239.
  • 10Braithwaite S,Barr W, Thomsa J. Diabetes management during glucocorticoid therapy for nonendocrine disease. Endocrine Practice1996; 17(2):320 - 325.

共引文献6835

同被引文献16

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部